Atlas Trials

Clazakizumab in Highly-HLA Sensitized Patients Awaiting Renal Transplant

Clinical trial NCT03380962 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03380962
Sponsor
Stanley Jordan, MD
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Kidney Failure, ChronicEnd-Stage Renal DiseaseTransplant GlomerulopathyTransplant;Failure,KidneyKidney Transplant Failure and RejectionAntibody-mediated RejectionKidney Transplant; Complications
Start date
2018-02-27
Primary completion
2025-08-30
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.